IGF2BP2 genetic variation and type 2 diabetes: A global meta-analysis

DNA and Cell Biology

Volumn 31, Issue 5, 2012, Pages 713-720

  Zhao, Yuan ^a   Ma, Yu Shui ^a   Fang, Ying ^a   Liu, Lili ^a   Wu, Sheng Di ^a   Fu, Da ^a,b   Wang, Xiao Feng ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHNICITY; GENE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN LIKE GROWTH FACTOR 2 MRNA BINDING PROTEIN 2 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 2; DNA; ETHNIC GROUPS; FAR EAST; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RISK FACTORS; RNA-BINDING PROTEINS;

EID: 84861350361     PISSN: 10445498     EISSN: 15577430     Source Type: Journal    
DOI: 10.1089/dna.2011.1400     Document Type: Article

References (48)

1. Altshuler, D., Hirschhorn, J.N., Klannemark, M., et al. (2000). The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26, 76-80.
2. Baier, L.J., and Hanson, R.L. (2004). Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle. Diabetes 53, 1181-1186. (Pubitemid 38569001)
3. Bronstein, M., Pisanté, A., Yakir, B., and Darvasi, A. (2008). Type 2 diabetes susceptibility loci in the Ashkenazi Jewish population. Hum Genet 124, 101-104.
4. Cauchi, S., Meyre, D., and Durand, E. (2008a). Post genomewide association studies of novel genes associated with type 2 diabetes show gene-gene interaction and high predictive value. PLoS One 3, e2031.
5. Cauchi, S., Nead, K.T., Choquet, H., et al. (2008b). The genetic susceptibility to type 2 diabetes may be modulated by obesity status: implications for association studies. BMCMed Genet 9, 45.
6. Chauhan, G., Spurgeon, C.J., et al. (2010). Impact of common variants of PPARG, KCNJ11, TCF7L2, SLC30A8, HHEX, CDKN2A, IGF2BP2 and CDKAL1 on the risk of type 2 diabetes in 5164 Indians. Diabetes 59, 2068-2074.
7. Christiansen, J., Kolte, A.M., Hansen, T.O., and Nielsen, F.C. (2009). Igf2 mrna-binding protein 2: biological function and putative role in type 2 diabetes. J Mol Endocrinol 43, 187-195.
8. Cugino, D., Gianfagna, F., Santimone, I., de Gaetano, G., Donati, M.B., Iacoviello, L., and Di Castelnuovo, A. (2011). Type 2 diabetes and polymorphisms on chromosome 9p21: a metaanalysis. Nutr Metab Cardiovasc Dis [Epub ahead of print]; DOI: 10 016/j.numecd.2010.11.0101.
9. Duesing, K., Fatemifar, G., Charpentier, G., et al. (2008). Evaluation of the association of IGF2BP2 variants with type 2 diabetes in French Caucasians. Diabetes 57, 1992-199.
10. Egger, M., Davey Smith, G., Schneider, M., and Minder, C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629-634. (Pubitemid 27387172)
11. Frayling, T.M., Timpson, N.J., Weedon, M.N., et al. (2007). A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316, 889-894. (Pubitemid 46764279)
12. Gloyn, A.L., Weedon, M.N., Owen, K.R., et al. (2003). Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes. Diabetes 52, 568-572. (Pubitemid 36173218)
13. Grarup, N., Rose, C.S., Andersson, E.A., et al. (2007). Studies of association of variants near the HHEX, CDKN2A/B and IGF2BP2 genes with type 2 diabetes and impaired insulin release in 10,705 Danish subjects: validation and extension of genome-wide association studies. Diabetes 56, 3105-3111. (Pubitemid 350223649)
14. Han, X., Luo, Y., Ren, Q., et al. (2010). Implication of genetic variants near SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, FTO, TCF2, KCNQ1, and WFS1 in type 2 diabetes in a Chinese population. BMC Med Genet 11, 81.
15. Herder, C., Rathmann, W., Strassburger, K., et al. (2008). Variants of the PPARG, IGF2BP2, CDKAL1, HHEX, and TCF7L2 genes confer risk of type 2 diabetes independently of BMI in the German KORA studies. Horm Metab Res 40, 722-726.
16. Horikawa, Y., Miyake, K., Yasuda, K., Enya, M., Hirota, Y., et al. (2008). Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan. J Clin Endocrinol Metab 93, 3136-3141.
17. Horikoshi, M., Hara, K., Ito, C., Shojima, N., Nagai, R., Ueki, K., Froguel, P., and Kadowaki, T. (2007). Variations in the HHEX gene are associated with increased risk of type 2 diabetes in the Japanese population. Diabetologia 50, 2461-2466. (Pubitemid 350060646)
18. Huang, Q., Yin, J.Y., Dai, X.P., et al. (2010). IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Acta Pharmacol Sin 31, 709-717.
19. Hu, C., Zhang, R., Wang, C., et al. (2009). PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 are associated with type 2 diabetes in a Chinese population. PLoS One 4, e7643.
20. Lee, Y.H., Kang, E.S., Kim, S.H., Han, S.J., Kim, C.H., Kim, H.J., Ahn, C.W., Cha, B.S., Nam, M., Nam, C.M., and Lee, H.C. (2008). Association between polymorphisms in SLC30A8, HHEX, CDKN2A/B, IGF2BP2, FTO, WFS1, CDKAL1, KCNQ1 and type 2 diabetes in the Korean population. J Hum Genet 53, 991-998.
21. Lewis, J.P., Palmer, N.D., Hicks, P.J., Sale, M.M., Langefeld, C.D., Freedman, B.I., Divers, J., and Bowden, D.W. (2008).Association analysis in African Americans of Europeanderived type 2 diabetes single nucleotide polymorphisms from whole-genome association studies. Diabetes 57, 2220-2225.
22. Lin, Y., Li, P., Cai, L., et al. (2010). Association study of genetic variants in eight genes/loci with type 2 diabetes in a Han Chinese population. BMC Med Genet 11, 97.
23. Liu, Y., Yu, L., Zhang, D., et al. (2008). Positive association between variations in CDKAL1 and type 2 diabetes in Han Chinese individuals. Diabetologia 51, 2134-2137.
24. Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., et al. (2008).Clinical risk factors, DNA variants, and the development of type 2 diabetes. N Engl J Med 359, 2220-2232.
25. Ng, M.C., Park, K.S., Oh, B., Tam, C.H., Cho, Y.M., et al. (2008).Implication of genetic variants near TCF7L2, SLC30A8, HHEX, CDKAL1, CDKN2A/B, IGF2BP2, and FTO in type 2 diabetes and obesity in 6,719 Asians. Diabetes 57, 2226-2233.
26. Nielsen, J., Christiansen, J., Lykke-Andersen, J., Johnsen, A.H., Wewer, U.M., and Nielsen, F.C. (1999). A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19, 1262-1270. (Pubitemid 29046868)
27. Omori, S., Tanaka, Y., Takahashi, A., et al. (2008). Association of CDKAL1, IGF2BP2, CDKN2A/B, HHEX, SLC30A8, and KCNJ11 with susceptibility to type 2 diabetes in a Japanese population. Diabetes 57, 791-795.
28. O'Rahilly, S., Barroso, I., and Wareham, N.J. (2005). Genetic factors in type 2 diabetes: the end of the beginning? Science 307, 370-373. (Pubitemid 40139970)
29. Rees, S.D., Hydrie, M.Z., Shera, A.S., et al. (2011). Replication of 13 genome-wide association (GWA)-validated risk variants for type 2 diabetes in Pakistani populations. Diabetologia 54, 1368-1374.
30. Rodriguez, S., Eiriksdottir, G., Gaunt, T.R., Harris, T.B., Launer, L.J., Gudnason, V., and Day, I.N. (2010). IGF2BP1, IGF2BP2 and IGF2BP3 genotype, haplotype and genetic model studies in metabolic syndrome traits and diabetes. Growth Horm IGF Res 20, 310-318.
31. Rong, R., Hanson, R.L., Ortiz, D., Wiedrich, C., Kobes, S., Knowler, W.C., Bogardus, C., and Baier, L.J. (2009). Association analysis of variation in/near FTO, CDKAL1, SLC30A8, HHEX, EXT2, IGF2BP2, LOC387761, and CDKN2B with type 2 diabetes and related quantitative traits in Pima Indians. Diabetes 58, 478-488.
32. Sandhu, M.S., Weedon, M.N., Fawcett, K.A., et al. (2007). Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet 39, 951-953. (Pubitemid 47185173)
33. Sanghera, D.K., Ortega, L., Han, S., Singh, J., Ralhan, S.K., Wander, G.S., Mehra, N.K., et al. (2008). Impact of nine common type 2 diabetes risk polymorphisms in Asian Indian Sikhs: PPARG2 (Pro12Ala), IGF2BP2, TCF7L2 and FTO variants confer a significant risk. BMC Med Genet 9, 59.
34. Saxena, R., Voight, B.F., Lyssenko, V., et al. (2007). Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels. Science 316, 1331-1336. (Pubitemid 46871653)
35. Scott, L.J., Mohlke, K.L., Bonnycastle, L.L., et al. (2007). A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants. Science 316, 1341-1345. (Pubitemid 46871655)
36. Shu,X.O., Long, J., Cai, Q., et al. (2010). Identification of new genetic risk variants for type 2 diabetes. PLoS Genet 6, e1001127.
37. Sladek, R., Rocheleau, G., Rung, J., et al. (2007). A genome-wide association study identifies novel risk loci for type 2 diabetes. Nature 445, 881-885.
38. Tabara, Y., Osawa, H., Kawamoto, R., Onuma, H., Shimizu, I., Miki, T., Kohara, K., and Makino, H. (2009). Replication study of candidate genes associated with type 2 diabetes based on genome-wide screening. Diabetes 58, 493-498.
39. Takeuchi, F., Ochiai, Y., Serizawa, M., et al. (2008). Search for type 2 diabetes susceptibility genes on chromosomes 1q, 3q and 12q. J Hum Genet 53, 314-324.
40. Takeuchi, F., Serizawa, M., Yamamoto, K., Fujisawa, T., et al. (2009). Confirmation of multiple risk Loci and genetic impacts by a genome-wide association study of type 2 diabetes in the Japanese population. Diabetes 58, 1690-1699.
41. Tan, J.T., Ng, D.P., Nurbaya, S., et al. (2010). Polymorphisms identified through genome-wide association studies and their associations with type 2 diabetes in Chinese, Malays, and Asian-Indians in Singapore. J Clin Endocrinol Metab 95, 390-397.
42. Unoki, H., Takahashi, A., Kawaguchi, T., et al. (2008). SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations. Nat Genet 40, 1098-1102.
43. van Hoek, M., Dehghan, A., Witteman, J.C., et al. (2008). Predicting type 2 diabetes based on polymorphisms from genome-wide association studies: a population-based study. Diabetes 57, 3122-3128.
44. Wen, J., Rönn, T., Olsson, A., et al. (2010). Investigation of type 2 diabetes risk alleles support CDKN2A/B, CDKAL1, and TCF7L2 as susceptibility genes in a Han Chinese cohort. PLoS One 5, e9153.
45. Wilson, P.W., Meigs, J.B., Sullivan, L., Fox, C.S., Nathan, D.M., and D'Agostino, R.B., Sr. (2007). Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167, 1068-1074. (Pubitemid 46835795)
46. Wu, Y., Li, H., Loos, R.J., Yu, Z., Ye, X., Chen, L., Pan, A., Hu, F.B., and Lin, X. (2008). Common variants in CDKAL1, CDKN2A/B, IGF2BP2, SLC30A8, and HHEX/IDE genes are associated with type 2 diabetes and impaired fasting glucose in a Chinese Han population. Diabetes 57, 2834-2842.
47. Xu, M., Bi, Y., Xu, Y., et al. (2010). Combined effects of 19 common variations on type 2 diabetes in Chinese: results from two community-based studies, PLoS One 5, e14022.
48. Zeggini, E., Weedon, M.N., Lindgren, C.M., Frayling, T.M., Elliott, K.S., Lango, H., Timpson, N.J., et al. (2007). Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes. Science 316, 1336-1341. (Pubitemid 46871654)